maralixibat chloride

Spain

Drugs containing this active substance

  • LIVMARLI 9.5 MG/ML ORAL SOLUTION

    It is used to treat cholestatic pruritus in patients with Alagille syndrome (from 2 months of age) and to treat progressive familial intrahepatic cholestasis (from 3 months of age). It helps to remove bile acids from the body.

    Form: solution, oral

    Active substance Dosage
    maralixibat chloride 300 mg

    ATC: A05A A05AX A05AX04

    Manufacturer: Mirum Pharmaceuticals International B.V.